CUE financials
Cue Biopharma (CUE) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
CUE income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $27.47M | – | -$26.55M | -$26.60M | -8.40 |
| 2024 | $9.29M | – | -$41.50M | -$40.67M | -21.60 |
| 2023 | $5.49M | – | -$52.15M | -$50.73M | -33.30 |
| 2022 | $1.25M | – | -$53.23M | -$53.01M | -44.70 |
| 2021 | $14.94M | – | -$43.71M | -$44.16M | -42.30 |
| 2020 | $3.15M | – | -$45.04M | -$44.78M | -46.80 |
- CUE revenue was $27.47M in fiscal 2025, net income -$26.60M.
Updated 2026-11-18 05:48 UTC